SCHEMBL19213826

SCHEMBL19213826

c1ccc(-c2ccc(-n3c4ccc(-c5ccc6c(c5)c5ccccc5n6-c5ccc6c7c(cccc57)-c5ccccc5-6)cc4c4ccc5ccccc5c43)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE6D O43924 1/20 0.35
TSPO P30536 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
CASP1 P29466 1/20 0.32
HIF1A Q16665 1/20 0.32
HSD17B10 Q99714 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ATM Q13315 1/20 0.31
PTGES O14684 1/20 0.31
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19213824 0.97 PDE6D (0.36) PDE6DTSPOL3MBTL1ALDH1A1HPGD
SCHEMBL17854638 0.96 L3MBTL1 (0.35) TSPOL3MBTL1ALDH1A1HPGDTSHR
SCHEMBL19213825 0.95 TSPO (0.33) PDE6DTSPOL3MBTL1ALDH1A1HPGD
SCHEMBL19213814 0.94 L3MBTL1 (0.34) L3MBTL1ALDH1A1HPGDTSHRMAPK1
SCHEMBL19213805 0.94 L3MBTL1 (0.34) L3MBTL1ALDH1A1HPGDTSHRMAPK1
SCHEMBL17854639 0.93 L3MBTL1 (0.39) PDE6DTSPOL3MBTL1ALDH1A1HPGD
SCHEMBL19213760 0.92 L3MBTL1 (0.34) L3MBTL1ALDH1A1HPGDTSHRMAPK1
SCHEMBL19213829 0.92 L3MBTL1 (0.34) PDE6DTSPOL3MBTL1ALDH1A1HPGD
SCHEMBL19213821 0.92 ALDH1A1 (0.32) L3MBTL1ALDH1A1HPGDTSHRMAPK1
SCHEMBL19213804 0.91 L3MBTL1 (0.38) L3MBTL1ALDH1A1HPGDTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10170707-B2 Compound, material for organic electroluminescence element, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-01-01 US disclosed
US-20180145265-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-24 US disclosed
US-20180145265-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-24 US disclosed
US-20170229661-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-08-10 US disclosed
US-20170229661-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170229661-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE RER1, LEF1, L1CAM PDE6D 2312/4885TSPO 2123/4885L3MBTL1 223/4885
US-20180145265-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE RER1, LEF1, L1CAM PDE6D 2312/4885TSPO 2123/4885L3MBTL1 223/4885
US-10170707-B2 Compound, material for organic electroluminescence element, organic electroluminescence element, and electronic device RER1, LEF1, L1CAM PDE6D 2312/4885TSPO 2123/4885L3MBTL1 223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.